<div id="readability-page-1"><p>In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Humana, with a price target of <span id="expert-recommendation-target">$322.00</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Hendrix covers the Healthcare sector, focusing on stocks such as CVS Health, Brookdale Senior Living, and Select Medical. According to TipRanks, Hendrix has an average return of <span>4.6%</span> and a 51.76% success rate on recommended stocks. </p> <p>In addition to RBC Capital, Humana also received a Buy from Jefferies’s David Windley in a report issued on December 5. However, on December 18, Morgan Stanley maintained a Hold rating on Humana (NYSE: HUM).</p></div>

<p>RBC Capital's Ben Hendrix maintained a Buy rating on Humana with a $322 price target. Hendrix, who covers the Healthcare sector, has a 4.6% average return and a 51.76% success rate. Jefferies also rated Humana as Buy, while Morgan Stanley maintained a Hold rating.</p>

RBC Capital Sticks to Its Buy Rating for Humana (HUM)